Duncan Williams Asset Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$688K Hold
70,281
0.16% 79
2026
Q1
$683K Hold
70,281
0.19% 77
2025
Q4
$625K Sell
70,281
-18,058
-20% -$184K 0.16% 86
2025
Q3
$862K Hold
88,339
0.24% 66
2025
Q2
$536K Hold
88,339
0.17% 88
2025
Q1
$1.09M Buy
88,339
+19,140
+28% +$271K 0.39% 43
2024
Q4
$958K Buy
69,199
+20,450
+42% +$323K 0.38% 45
2024
Q3
$816K Buy
+48,749
New +$1.05M 0.45% 45

Other funds holding PRTA

Duncan Williams Asset Management's PRTA Position: Q2 2026 in Review

Duncan Williams Asset Management held its Prothena Corp (PRTA) position steady in Q2 2026 at 70,281 shares worth $688K. The position accounts for 0.16% of the portfolio, ranked #79.

Duncan Williams Asset Management first reported a position in PRTA in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.09M in Q1 2025. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Duncan Williams Asset Management held 70,281 shares of Prothena Corp worth $688K as of Q2 2026.
  • Duncan Williams Asset Management left its Prothena Corp share count unchanged in Q2 2026.
  • Prothena Corp made up 0.16% of Duncan Williams Asset Management's portfolio in Q2 2026, its #79 holding.
  • Duncan Williams Asset Management first reported a position in Prothena Corp in Q3 2024 and has held it in 8 quarters since.
  • Duncan Williams Asset Management's Prothena Corp position peaked at $1.09M in Q1 2025.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Duncan Williams Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.